Related Experiment Videos
Chemotherapy Foundation Symposium XVIII: Session on malignant melanoma
1University of Pittsburgh Cancer Institute, PA 15213, USA. agarwalass@msx.upmc.edu
Expert Opinion on Investigational Drugs
|June 27, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Melanoma: immunotherapeutic approaches.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment.
Expert opinion on biological therapy·2001
Phase 1, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer.
Cytokines, cellular & molecular therapy·2001
Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders.
Expert opinion on investigational drugs·2026
Telisotuzumab adizutecan for metastatic colorectal cancer: a c-MET-targeted antibody-drug conjugate with a topoisomerase inhibitor payload.
Expert opinion on investigational drugs·2026
Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.
Expert opinion on investigational drugs·2026
Receptor interacting protein kinase 1 as a potential therapeutic target in inflammatory bowel disease: biological rationale and emerging clinical evidence.
Expert opinion on investigational drugs·2026
Budigalimab: a viable option for patients with advanced solid tumors.
Expert opinion on investigational drugs·2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Expert opinion on investigational drugs·2026
Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Association between ineffective health self-management and severe radiodermatitis: Cohort study.
International journal of nursing knowledge·2026
Systematic review: Stereotactic Body Radiation Therapy for Pancreatic Cancer: Evaluating its Efficacy, Safety, and Future Prospects.
The British journal of radiology·2026
A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis.
Indian journal of ophthalmology·2026